Shares of Becton Dickinson & Co. BDX slipped 2.13% to $221.59 Thursday, on what proved to be an all-around dismal trading ...

Generation Investment Management, an investment management firm, released its “Global Equity Strategy” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. The firm is not ...

Becton, Dickinson and Co. also reported slightly higher pay for the device developer and manufacturer's median worker in ...

BD (Becton, Dickinson and Company) , a leading global medical technology company, today announced that BD management will host an audio webcast at 8 a.m. ET on Thursday, May 1, 2025 to discuss the ...

In addition to job gains, local leaders see Arizona emerging as one of the nation’s most dynamic hubs for bioscience ...

Select stocks may be just fine despite tariffs and the economic damage they could cause. The S&P 500 plummeted 4.8% Thursday ...

The global ureteral stent market is experiencing significant growth, with the market projected to rise from USD 385.9 million in 2022 to a promising USD 616.8 million by 2032, advancing at a steady ...

The global disposable insulin-delivery device market is projected to experience robust growth over the next decade, according to recent industry insights. Valued at USD 14,585.6 million in 2022, the ...

The global point of care blood testing devices market is on a rapid upward trajectory, with projections indicating a remarkable expansion to an estimated value of USD 49,973.6 million by 2032. This ...